Piper Sandler Reiterates Neutral Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

Piper Sandler reissued their neutral rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report released on Friday, Benzinga reports. The brokerage currently has a $32.00 price target on the medical instruments supplier’s stock, down from their prior price target of $35.00.

Several other research analysts have also weighed in on the stock. StockNews.com raised shares of DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Barrington Research reiterated an outperform rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research note on Friday. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a report on Friday. Finally, Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of Moderate Buy and an average target price of $36.90.

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ:XRAY opened at $28.29 on Friday. The stock has a market cap of $5.87 billion, a price-to-earnings ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $26.27 and a one year high of $41.65. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43. The business’s 50-day simple moving average is $32.13 and its 200 day simple moving average is $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period in the prior year, the company posted $0.39 EPS. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, sell-side analysts predict that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.26%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Institutional Trading of DENTSPLY SIRONA

Hedge funds have recently added to or reduced their stakes in the business. VisionPoint Advisory Group LLC grew its stake in shares of DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Principal Securities Inc. bought a new position in DENTSPLY SIRONA in the 4th quarter valued at about $26,000. Headlands Technologies LLC acquired a new position in DENTSPLY SIRONA during the 4th quarter valued at about $30,000. Parkside Financial Bank & Trust raised its position in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $47,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.